← Back to Search

Cell Therapy

RECELL 1:5 for Vitiligo

N/A
Waitlist Available
Research Sponsored by Avita Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4, 12 and 24 weeks
Awards & highlights

Study Summary

This trial will test whether a new treatment called RECELL can help repigment areas of the skin that have lost color. The trial will involve 10 people with 50 areas of depigmented skin each.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4, 12 and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4, 12 and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Repigmentation
Secondary outcome measures
Blinded Evaluator Color Matching
Categorization of Repigmentation
Responders
+1 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: RECELL 1:5Experimental Treatment1 Intervention
Regenerative epidermal suspension diluted 1:5 applied to a surgically prepared area of depigmentation
Group II: RECELL 1:20Experimental Treatment1 Intervention
Regenerative epidermal suspension diluted 1:20 applied to a surgically prepared area of depigmentation
Group III: RECELL 1:10Experimental Treatment1 Intervention
Regenerative epidermal suspension diluted 1:10 applied to a surgically prepared area of depigmentation
Group IV: ControlActive Control1 Intervention
Area without surgical intervention. Ultraviolet Lamp (UVB)
Group V: Melanocyte-Keratinocyte TransplantationActive Control1 Intervention
Autologous skin cell suspension prepared by laboratory based melanocyte-keratinocyte transplantation procedure technique applied to a surgically prepared area of depigmentation

Find a Location

Who is running the clinical trial?

Avita MedicalLead Sponsor
15 Previous Clinical Trials
645 Total Patients Enrolled
4 Trials studying Vitiligo
161 Patients Enrolled for Vitiligo

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Connecticut
California
How old are they?
18 - 65
< 18
What site did they apply to?
University of Massachusetts
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions
2020. "Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04271501.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top